Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, announced a multi-target collaboration with Novartis to identify and develop potentially first-in-class ...

Defiant is a new early stage VC firm focused on B2B SaaS and fintech coming out of stealth Thursday. Joseph Pizzolato ...

Cytovale®, a commercial-stage medical diagnostics company, today celebrated a monumental year that catapulted it to lead the emerging sepsis diagnostics market, driven by increased demand for ...